Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (351-360 of 418) with videos related to

Pageof 42
Sort By:
The British Journal of Dermatology|February 8, 2023
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trialsGeorgios Kokolakis, Richard B Warren, Bruce Strober, et al.
Dermatology Online Journal|October 31, 2025
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panelLauren DeBusk, Natasha Atanaskova-Mesinkovska, Brooke Bartley, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitisCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Development of the Generalized Pustular Psoriasis Clinical Assessment ToolAmit Garg, Megan H Noe, Milan J Anadkat, et al.
Journal of the American Academy of Dermatology|February 28, 2002
Cost of atopic dermatitis and eczema in the United StatesCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Therapeutic Advances in Chronic Disease|November 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publicationDavid Rosmarin, Thierry Passeron, Amit G Pandya, et al.
The New England Journal of Medicine|October 19, 2022
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for VitiligoDavid Rosmarin, Thierry Passeron, Amit G Pandya, et al.
Human Mutation|August 9, 2005
Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6Sara Miksch, Amanda Lumsden, Ulf P Guenther, et al.
The Journal of Dermatological Treatment|August 9, 2021
The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statementDaniel C Butler, Eric Simpson, Emma Guttman-Yassky, et al.
Journal of the American Academy of Dermatology|September 20, 2020
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)Mark Lebwohl, Leon Kircik, Jean-Philippe Lacour, et al.
Pageof 42

Showing results (351-360 of 418) with videos related to

Sort By:
Pageof 42
The British Journal of Dermatology|February 8, 2023
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trialsGeorgios Kokolakis, Richard B Warren, Bruce Strober, et al.
Dermatology Online Journal|October 31, 2025
The role of interleukin-13 in the management of atopic dermatitis: an expert consensus panelLauren DeBusk, Natasha Atanaskova-Mesinkovska, Brooke Bartley, et al.
Journal of the American Academy of Dermatology|March 29, 2003
Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitisCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Development of the Generalized Pustular Psoriasis Clinical Assessment ToolAmit Garg, Megan H Noe, Milan J Anadkat, et al.
Journal of the American Academy of Dermatology|February 28, 2002
Cost of atopic dermatitis and eczema in the United StatesCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Therapeutic Advances in Chronic Disease|November 10, 2025
Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publicationDavid Rosmarin, Thierry Passeron, Amit G Pandya, et al.
The New England Journal of Medicine|October 19, 2022
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for VitiligoDavid Rosmarin, Thierry Passeron, Amit G Pandya, et al.
Human Mutation|August 9, 2005
Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6Sara Miksch, Amanda Lumsden, Ulf P Guenther, et al.
The Journal of Dermatological Treatment|August 9, 2021
The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statementDaniel C Butler, Eric Simpson, Emma Guttman-Yassky, et al.
Journal of the American Academy of Dermatology|September 20, 2020
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)Mark Lebwohl, Leon Kircik, Jean-Philippe Lacour, et al.
Pageof 42